The role and clinical applications of bioactive lysolipids in ovarian cancer

Journal of the Society for Gynecologic Investigation

Volumn 8, Issue 1, 2001, Pages 1-13

  Sommer, S G ^a  

^a DANISH INSTITUTE OF AGRICULTURAL SCIENCES   (Denmark)

Author keywords

Bioactive lysolipids; Clinical management; Diagnosis; Lysophosphatidic acid; Ovarian cancer

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; RECEPTOR; SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE; TUMOR MARKER;

ASCITES; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL STRUCTURE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0035793032     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1177/107155760100800101     Document Type: Review

References (235)

1. Is early detection of ovarian cancer possible?
2. Screening for early ovarian cancer
3. Growth factors in human ovarian cancer
4. Human ovarian cancer of the surface epithelium
5. Biological therapy of ovarian cancer; Current directions
6. Lipid second messengers
7. Bioactive lysophospholipids and their G protein-coupled receptors
8. Dual actions of sphingosine-1-phosphate; Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival
9. Sphingolipid metabolites; Members of a new class of lipid second messengers
10. Lysophosphatidic acid; G-protein signalling and cellular responses
11. Molecular diversity of sphingolipid signalling
12. Sphingosine 1-phosphate; a prototype of a new class of second messengers
13. Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells
14. Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture
15. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells
16. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation
17. The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation differentiation and death
18. Roles of sphingosine-1-phosphate in cell growth differentiation and death
19. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis
20. Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells
21. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma
22. Role of lysophosphatidic acid and rho in glioma cell motility
23. Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA)
24. Endothelial cell mitogenesis induced by LPA; Inhibition by thrombospondin-1 and thrombospondin-2
25. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton
26. Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors
27. Sphingosine-1-phosphate inhibits extracellular matrix protein-induced haptotactic motility but not adhesion of B16 mouse melanoma cells
28. Molecular identification and characterization of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate
29. Sphingosine 1-phosphate a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness
30. Sphingosine-1-phosphate a novel second messenger involved in cell growth regulation and signal transduction affects growth and invasiveness of human breast cancer cells
31. Invasion of T-lymphoma cells; Cooperation between Rho family GTPases and lysophospholipid receptor signaling
32. Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers
33. Lysophosphatidic acid induces neuronal shape changes via a novel receptor-mediated signaling pathway; Similarity to thrombin action
34. Restoration of beta1A integrins is required for lysophosphatidic acid-induced migration of beta1-null mouse fibroblastic cells
35. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid potential mediators of hematopoietic angiogenesis
36. Sphingosine 1-phosphate; A ligand for the EDG-1 family of G-protein-coupled receptors
37. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells; Spatial and temporal modulation of PDGF chemotactic signal transduction
38. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid
39. Lysophosphatidic acid alkylglycerophosphate and alkylacetylglycerophosphate increase the neuronal nuclear acetylation of 1-acyl lysophosphatidyl choline by inhibition of lysophospholipase
40. Sphingosine-1-phosphate induces a Ca2+ signal in primary rat astrocytes and a Ca2+ signal and shape changes in C6 rat glioma cells
41. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction; Action through a specific cell surface receptor
42. Sphingosine-1-phosphate; A platelet-activating sphingolipid released from agonist-stimulated human platelets
43. Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA
44. Lysophosphatidic acid stimulates actomyosin contraction in astrocytes
45. Lysophosphatidic acid enhances contractility of isolated airway smooth muscle
46. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro
47. Modulation of smooth muscle contraction by sphingosylphosphorylcholine
48. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid
49. Signalling properties of lysophosphatidic acid in primary human skin fibroblasts; role of pertussis toxin-sensitive GTP-binding proteins
50. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development
51. A new wound healing agent-sphingosylphosphorylcholine
52. Rho-mediated protein tyrosine phosphorylation in lysophosphatidic-acid-induced tumor-cell invasion
53. Lysophosphatidic acid is a chemoattractant for Dictyostelium discoideum amoebae
54. High specificity of human secretory class II phospholipase A2 for phosphatidic acid
55. Sphingosine-1-phosphate; Characterization of its inhibition of platelet aggregation
56. Identification of lysophospholipid receptors in human platelets; the relation of two agonists lysophosphatidic acid and sphingosine 1-phosphate
57. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation
58. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid
59. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation
60. Lysophosphatidic acid induces inward currents in Xenopus laevis oocytes; evidence for an extracellular site of action
61. The influence of lysophosphatidic acid on platelet protein phosphorylation
62. Platelet aggregating activity of lysophosphatidic acids is not related to their calcium ionophore properties
63. Phospholipid-induced human platelet activation; effects of calcium channel blockers and calcium chelators
64. Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog rabbit and human platelets
65. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives; Identity with substances in aged serum (DAS)
66. Sphingosine-1-phosphate; characterization of its inhibition of platelet aggregation [In Process Citation]
67. Sphingolipid metabolism during human platelet activation
68. The biological activity of acetylated sphingosylphosphorylcholine derivatives
69. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
70. Lysophosphatidic acid induction of transforming growth factors alpha and beta; Modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin
71. Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway
72. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1; A critical role for the mitogen-activated protein kinase p38 and for Rho proteins
73. Structural requirements of sphingosylphosphocholine and sphingosine-1- phosphate for stimulation of activator protein-1 activity
74. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes
75. Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells
76. Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils; involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production
77. Ceramide prevents motoneuronal cell death through inhibition of oxidative signal
78. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase
79. Sphingosylphosphorylcholine induces cytosolic Ca(2+) elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery [published erratum appears in FEBS Lett 2000 Jan 28;466(2-3):395]
80. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
81. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells
82. Malignant effusions contain lysophosphatidic acid (LPA)-like activity
83. Lysophosphatidic acid and mesangial cells; Implications for renal diseases
84. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
85. The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like tau phosphorylation
86. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers [see comments]
87. Sphingolipids-the enigmatic lipid class; biochemistry physiology and pathophysiology
88. Sphingosylphosphocholine a signaling molecule which accumulates in Niemann-Pick disease type A stimulates DNA-binding activity of the transcription activator protein AP-1
89. Niemann-Pick disease types A and B
90. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate
91. Lysophospholipid receptors; Implications for neural signaling
92. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs)
93. Sphingosine 1-phosphate signalling in mammalian cells
94. Life on the edg
95. Development of our current understanding of bioactive lysophospholipids [In Process Citation]
96. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway
97. Characterization of a novel sphingosine 1-phosphate receptor Edg-8
98. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
99. The role of sphingosine in cell growth regulation and transmembrane signaling
100. Sphingosine and sphingosine 1-phosphate in cellular proliferation; Relationship with protein kinase C and phosphatidic acid
101. Sphingosine-1-phosphate; A novel second messenger involved in cell growth regulation and signal transduction affects growth and invasiveness of human breast cancer cells
102. Intracellular calcium release mediated by sphingosine derivatives generated in cells
103. Sphingolipids increase calcium concentration in isolated rat liver nuclei
104. Sphingosylphosphorylcholine increases calcium concentration in isolated brain nuclei
105. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils
106. Activation of a Ca2+-dependent K+ current in mouse fibroblasts by lysophosphatidic acid requires a pertussis toxin-sensitive G protein and Ras
107. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes
108. Evidence for edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes [In Process Citation]
109. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes
110. Lysophosphatidic acid induces a pertussis toxin-sensitive Ca(2+)-activated Cl- current in Xenopus laevis oocytes
111. Responses to sphingosine-1-phosphate in X. laevis oocytes; Similarities with lysophosphatidic acid signaling
112. Growth factor-like action of lysophosphatidic acid; Mitogenic signalling mediated by G proteins
113. Sphingosine 1-phosphate induces arachidonic acid mobilization in A549 human lung adenocarcinoma cells
114. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts
115. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate
116. Downregulation of mRNA expression of Edg-3 a putative sphingosine 1-phosphate receptor coupled to Ca2+ signaling during differentiation of HL-60 leukemia cells
117. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways
118. Sphingosine 1-phosphate stimulates hydrogen peroxide generation through activation of phospholipase C-Ca2+ system in FRTL-5 thyroid cells; Possible involvement of guanosine triphosphate-binding proteins in the lipid signaling
119. Involvement of pertussis toxin-sensitive GTP-binding proteins in sphingosine 1-phosphate-induced activation of phospholipase C-Ca2+ system in HL60 leukemia cells
120. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways
121. EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways including phospholipase C activation Ca2+ mobilization Ras-mitogen-activated protein kinase activation and adenylate cyclase inhibition
122. Activation of protein kinase C by lysophosphatidic acid; Dependence on composition of phospholipid vesicles
123. Protein kinase C-dependent regulation of human erythroleukemia (HEL) cell sphingosine kinase activity
124. Pertussis toxin- and PMA-insensitive calcium mobilization by sphingosine in CFPAC-1 cells; evidence for a phosphatidic acid-dependent mechanism
125. Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein
126. Lysophosphatidic acid inhibits epidermal-growth-factor-induced Stat1 signaling in human epidermoid carcinoma A431 cells
127. Lysophosphatidic acid sensitizes mechanical stress-induced Ca2+ response via activation of phospholipase C and tyrosine kinase in cultured smooth muscle cells
128. Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids
129. Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro
130. The biologically active phospholipid lysophosphatidic acid induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D. Comparison with the response to endothelin
131. Sphingosine-1-phosphate activates phospholipase D in human airway epithelial cells via a G protein-coupled receptor
132. Differential phospholipase D activation by bradykinin and sphingosine 1-phosphate in NIH 3T3 fibroblasts overexpressing gelsolin
133. Receptor-mediated activation of phospholipase D by sphingosine 1-phosphate in skeletal muscle C2C12 cells. A role for protein kinase C
134. Receptor-activated phospholipase D is present in caveolin-3-enriched light membranes of C2C12 myotubes
135. Activation of endothelial cell phospholipase D by sphingosine and sphingosine-1-phosphate
136. Exogenous sphingosine 1-phosphate and sphingosylphosphorylcholine do not stimulate phospholipase D in C6 glioma cells
137. PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor
138. A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis; Requirement for insulin- and lysophosphatidic acid-mediated signal transduction
139. Lysophosphatidic acid activates NF-kappaB in fibroblasts. A requirement for multiple inputs
140. Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells
141. Lysophosphatidic acid signalling
142. Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts
143. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16
144. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases
145. Lysophosphatidic acid induces neuronal shape changes via a novel receptor-mediated signaling pathway; similarity to thrombin action
146. Sphingosine 1-phosphate stimulates tyrosine phosphorylation of focal adhesion kinase and chemotactic motility of endothelial cells via the G(i) protein-linked phospholipase C pathway
147. Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p21rho in the signaling pathway
148. Sphingosine 1-phosphate stimulates rho-mediated tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts
149. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid
150. Potentiation of G-protein-coupled receptor-induced MAP kinase activation by exogenous EGF receptors in SK-N-MC neuroepithelioma cells
151. Lysophospholipids activate ovarian and breast cancer cells
152. Sphingosine 1-phosphate activation of MAP kinase-involvement of PI 3-kinase and protein kinase C
153. Differential stimulation of proline-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine 1-phosphate
154. Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway
155. Sphingolipid receptor signaling and function in human bladder carcinoma cells; Inhibition of LPA- but enhancement of thrombin-stimulated cell motility
156. Lipid recycling between the plasma membrane and intracellular compartments; transport and metabolism of fluorescent sphingomyelin analogues in cultured fibroblasts
157. Determination of the transbilayer distribution of fluorescent lipid analogues by nonradiative fluorescence resonance energy transfer
158. Development of our current understanding of bioactive lysophospholipids
159. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin
160. Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture
161. Lysophosphatidic acid-induced proliferation-related signals in astrocytes
162. Lysophosphatidic acid; A novel growth and survival factor for renal proximal tubular cells
163. Identification of a novel growth factor-like lipid 1-O-cis-alk-1′-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations
164. Sphingosine 1-phosphate-induced cell proliferation survival and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5
165. Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells
166. Sphingosine and sphingosine 1-phosphate in cellular proliferation; relationship with protein kinase C and phosphatidic acid
167. Sphingosine-1-phosphate in cell growth and cell death
168. The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF) a basic helix-loop-helix-zipper protein
169. Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway
170. Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines
171. Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes
172. Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine
173. Analysis of the proliferative response to lysophosphatidic acid in primary cultures of mammary epithelium; Differences between normal and tumor cells
174. Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells
175. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells
176. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
177. Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions
178. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner
179. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax
180. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons
181. Suppression of ceramide-mediated programmed cell death by sphingosine-1- phosphate
182. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide- mediated apoptosis in Jurkat T lymphocytes
183. Lysophospholipids activate ovarian and breast cancer cells
184. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
185. A putative new growth factor in ascitic fluid from ovarian cancer patients; Identification characterization and mechanism of action
186. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells
187. Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells
188. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses
189. Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells
190. Mechanisms of tumour metastasis
191. Cell adhesion molecules; An overview
192. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D
193. Invasion of T-lymphoma cells; Cooperation between Rho family GTPases and lysophospholipid receptor signaling
194. Tumor-host interaction; analysis of cytokines growth factors and tumor-infiltrating lymphocytes in ovarian carcinomas
195. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
196. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
197. The chemotactic cytokine interleukin-8-a cyst fluid marker for malignant epithelial ovarian cancer?
198. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells
199. Regulation of interleukin-8 gene expression by all-trans retinoic acid
200. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer
201. Intraperitoneal therapy of ovarian cancer
202. Intraperitoneal therapy of ovarian cancer
203. Carboplatin and paclitexal combination chemotherapy
204. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology; Analysis of interleukin (IL) 6, IL-8 and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype
205. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
206. Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist
207. Molecular cloning and characterization of a novel human G-protein-coupled receptor EDG7 for lysophosphatidic acid
208. Life on the edg
209. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer
210. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway
211. Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes
212. Okadaic acid activates p42 mitogen-activated protein kinase (MAP kinase;ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation; Contrast with phorbol 12-myristate 13-acetate
213. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells
214. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid
215. A factor that activates oscillatory chloride currents in Xenopus oocytes copurifies with a subfraction of serum albumin
216. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells
217. Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a 2b and 2c enzymes and cell surface activity of the 2a isoform
218. Identification of a novel human phosphatidic acid phosphatase type 2 isoform
219. Identification of the phosphatidic acid phosphatase type 2a isozyme as an androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaP
220. Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase
221. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells
222. Purification and assay of mammalian group I and group IIa secretory phospholipase A2
223. Mapping the interfacial binding surface of human secretory group IIa phospholipase A2
224. A phospholipase A2 kinetic and binding assay using phospholipid-coated hydrophobic beads
225. Exogenous phospholipase D generates lysophosphatidic acid and activates Ras Rho and Ca2+ signaling pathways